ZBIO logo

Zenas BioPharma, Inc. (ZBIO) EBITDA

Annual EBITDA:

-$163.75M-$136.72M(-505.72%)
December 31, 2024

Summary

  • As of today, ZBIO annual EBITDA is -$163.75 million, with the most recent change of -$136.72 million (-505.72%) on December 31, 2024.
  • During the last 3 years, ZBIO annual EBITDA has fallen by -$88.63 million (-117.98%).
  • ZBIO annual EBITDA is now -505.72% below its all-time high of -$27.03 million, reached on December 31, 2023.

Performance

1-Year Change

-505.72%

3-Year Change

-117.98%

5-Year Change

-117.98%

15-Year Change

-117.98%

ZBIO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

10.33%
ZBIO annual EBITDA is higher than 10.33% of companies in Healthcare sector

Range

All-Time High

-$27.03M
ZBIO annual EBITDA is currently -505.72% below its historical high of -$27.03 million

3-Year Low

-$163.75M
ZBIO annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ZBIO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 17, 2026
ZBIO next annual earnings announcement is scheduled for Mar 17, 2026

OtherZBIOincome statement metrics

Annual Revenue

$5.00M
ZBIO annual revenue is $5.00 million

Annual Net Income

-$156.99M
ZBIO annual net profit is -$156.99 million

Annual EBIT

-$163.89M
ZBIO annual earnings before interest & taxes is -$163.89 million

Annual EPS

-$3.76
ZBIO annual earnings per share is -$3.76

Quarterly EBITDA:

-$47.57M+$7.58M(+13.75%)
September 30, 2025

Summary

  • As of today, ZBIO quarterly EBITDA is -$47.57 million, with the most recent change of +$7.58 million (+13.75%) on September 30, 2025.
  • Over the past year, ZBIO quarterly EBITDA has dropped by -$6.62 million (-16.17%).
  • ZBIO quarterly EBITDA is now -233.43% below its all-time high of $35.65 million, reached on September 1, 2023.

Performance

3-Month Change

+13.75%

1-Year Change

-16.17%

3-Year Change

-150.84%

5-Year Change

-150.84%

ZBIO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

8.36%
ZBIO quarterly EBITDA is higher than 8.36% of companies in Healthcare sector

Range

All-Time High

$35.65M
ZBIO quarterly EBITDA is currently -233.43% below its historical high of $35.65 million

3-Year Low

-$55.59M
ZBIO quarterly EBITDA is currently +14.43% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ZBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 17, 2026
ZBIO next earnings announcement is scheduled for Mar 17, 2026

OtherZBIOincome statement metrics

Quarterly Revenue

$0.00
ZBIO quarterly revenue is $0.00

Quarterly Net Income

-$51.50M
ZBIO quarterly net profit is -$51.50 million

Quarterly EBIT

-$47.58M
ZBIO quarterly earnings before interest & taxes is -$47.58 million

Quarterly EPS

-$1.22
ZBIO quarterly earnings per share is -$1.22

TTM EBITDA:

-$195.62M-$6.62M(-3.50%)
September 30, 2025

Summary

  • As of today, ZBIO TTM EBITDA is -$195.62 million, with the most recent change of -$6.62 million (-3.50%) on September 30, 2025.
  • Over the past year, ZBIO TTM EBITDA has dropped by -$87.46 million (-80.86%).
  • ZBIO TTM EBITDA is now -1716.15% below its all-time high of -$10.77 million, reached on March 1, 2024.

Performance

3-Month Change

-3.5%

1-Year Change

-80.86%

3-Year Change

-931.52%

5-Year Change

-931.52%

ZBIO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

7.73%
ZBIO TTM EBITDA is higher than 7.73% of companies in Healthcare sector

Range

All-Time High

-$10.77M
ZBIO TTM EBITDA is currently -1716.15% below its historical high of -$10.77 million

3-Year Low

-$195.62M
ZBIO TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ZBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 17, 2026
ZBIO next earnings announcement is scheduled for Mar 17, 2026

OtherZBIOincome statement metrics

TTM Revenue

$15.00M
ZBIO TTM revenue is $15.00 million

TTM Net Income

-$189.90M
ZBIO TTM net profit is -$189.90 million

TTM EBIT

-$195.70M
ZBIO TTM earnings before interest & taxes is -$195.70 million

TTM EPS

-$4.53
ZBIO TTM earnings per share is -$4.53

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$163.75M
ZBIO annual EBITDA is -$163.75 million

Annual Net Income

-$156.99M
ZBIO annual net profit is -$156.99 million

Annual Interest Expense

$0.00
ZBIO annual interest expense is $0.00

Annual Income Tax

$429.00K
ZBIO annual income tax is $429.00 thousand

Annual D&A

$137.00K
ZBIO annual D&A is $137.00 thousand

ZBIO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-505.7%-16.2%-80.9%
3Y3 Years-118.0%-150.8%-931.5%
5Y5 Years-118.0%-150.8%-931.5%

ZBIO EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-505.7%at low-233.4%+14.4%-1716.2%at low
5Y5-Year-505.7%at low-233.4%+14.4%-1716.2%at low
All-TimeAll-Time-505.7%at low-233.4%+14.4%-1716.2%at low

ZBIO EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$47.57M(+13.7%)
-$195.62M(-3.5%)
Jun 2025
-
-$55.15M(-47.8%)
-$189.00M(-8.9%)
Mar 2025
-
-$37.31M(+32.9%)
-$173.51M(-6.0%)
Dec 2024
-$163.75M
-$55.59M(-35.8%)
-$163.75M(-51.4%)
Sep 2024
-
-$40.95M(-3.2%)
-$108.16M(-242.7%)
Jun 2024
-
-$39.67M(-44.0%)
-$31.56M(-193.0%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$27.55M(-177.3%)
-$10.77M(+49.3%)
Dec 2023
-$27.03M(+64.0%)
-
-
Sep 2023
-
$35.65M(+288.9%)
-$21.25M(+62.7%)
Jun 2023
-
-$18.88M(+1.0%)
-$56.90M(-49.6%)
Mar 2023
-
-$19.06M(-0.5%)
-$38.02M(-100.5%)
Dec 2022
-$75.12M
-$18.96M
-$18.96M

FAQ

  • What is Zenas BioPharma, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. annual EBITDA year-on-year change?
  • What is Zenas BioPharma, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. quarterly EBITDA year-on-year change?
  • What is Zenas BioPharma, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. TTM EBITDA year-on-year change?

What is Zenas BioPharma, Inc. annual EBITDA?

The current annual EBITDA of ZBIO is -$163.75M

What is the all-time high annual EBITDA for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high annual EBITDA is -$27.03M

What is Zenas BioPharma, Inc. annual EBITDA year-on-year change?

Over the past year, ZBIO annual EBITDA has changed by -$136.72M (-505.72%)

What is Zenas BioPharma, Inc. quarterly EBITDA?

The current quarterly EBITDA of ZBIO is -$47.57M

What is the all-time high quarterly EBITDA for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high quarterly EBITDA is $35.65M

What is Zenas BioPharma, Inc. quarterly EBITDA year-on-year change?

Over the past year, ZBIO quarterly EBITDA has changed by -$6.62M (-16.17%)

What is Zenas BioPharma, Inc. TTM EBITDA?

The current TTM EBITDA of ZBIO is -$195.62M

What is the all-time high TTM EBITDA for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high TTM EBITDA is -$10.77M

What is Zenas BioPharma, Inc. TTM EBITDA year-on-year change?

Over the past year, ZBIO TTM EBITDA has changed by -$87.46M (-80.86%)
On this page